0001209191-23-059032.txt : 20231218
0001209191-23-059032.hdr.sgml : 20231218
20231218184412
ACCESSION NUMBER: 0001209191-23-059032
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231214
FILED AS OF DATE: 20231218
DATE AS OF CHANGE: 20231218
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dar Zavain
CENTRAL INDEX KEY: 0001852075
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40323
FILM NUMBER: 231495141
MAIL ADDRESS:
STREET 1: C/O LUX CAPITAL MANAGEMENT, LLC
STREET 2: 1600 EL CAMINO REAL - SUITE 290
CITY: MENLO PARK
STATE: CA
ZIP: 94025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: RECURSION PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001601830
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 464099738
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 41S RIO GRANDE STREET
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84101
BUSINESS PHONE: (385) 269-0203
MAIL ADDRESS:
STREET 1: 41S RIO GRANDE STREET
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84101
FORMER COMPANY:
FORMER CONFORMED NAME: Recursion Pharmaceuticals, LLC
DATE OF NAME CHANGE: 20140305
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-12-14
0
0001601830
RECURSION PHARMACEUTICALS, INC.
RXRX
0001852075
Dar Zavain
C/O RECURSION PHARMACEUTICALS
41 S. RIO GRANDE STREET
SALT LAKE CITY
UT
84101
1
0
0
0
1
Class A Common Stock
2023-12-14
4
S
0
20141
9.00
D
53823
D
Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person on June 21, 2023
/s/Jonathan Golightly, attorney-in-fact
2023-12-18